These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 38860366)

  • 1. Interleukin-17A educated hepatic stellate cells promote hepatocellular carcinoma occurrence through fibroblast activation protein expression.
    Ni JS; Fu SY; Wang ZY; Ding WB; Huang J; Guo XG; Gu FM
    J Gene Med; 2024 Jun; 26(6):e3693. PubMed ID: 38860366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
    Ma HY; Yamamoto G; Xu J; Liu X; Karin D; Kim JY; Alexandrov LB; Koyama Y; Nishio T; Benner C; Heinz S; Rosenthal SB; Liang S; Sun M; Karin G; Zhao P; Brodt P; Mckillop IH; Quehenberger O; Dennis E; Saltiel A; Tsukamoto H; Gao B; Karin M; Brenner DA; Kisseleva T
    J Hepatol; 2020 May; 72(5):946-959. PubMed ID: 31899206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17a promotes hepatocellular carcinoma by increasing FAP expression in hepatic stellate cells via activation of the STAT3 signaling pathway.
    Sun D; Li W; Ding D; Tan K; Ding W; Wang Z; Fu S; Hou G; Zhou WP; Gu F
    Cell Death Discov; 2024 May; 10(1):230. PubMed ID: 38740736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma.
    Liao X; Bu Y; Chang F; Jia F; Song G; Xiao X; Zhang M; Ning P; Jia Q
    BMC Cancer; 2019 Dec; 19(1):1192. PubMed ID: 31805888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semaphorin 3C (Sema3C) reshapes stromal microenvironment to promote hepatocellular carcinoma progression.
    Peng H; Yang M; Feng K; Lv Q; Zhang Y
    Signal Transduct Target Ther; 2024 Jul; 9(1):169. PubMed ID: 38956074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cluster of differentiation 147 is a key molecule during hepatocellular carcinoma cell-hepatic stellate cell cross-talk in the rat liver.
    Ma T; Wang Z; Yang Z; Chen J
    Mol Med Rep; 2015 Jul; 12(1):111-8. PubMed ID: 25738354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts.
    Zhou Y; Ren H; Dai B; Li J; Shang L; Huang J; Shi X
    J Exp Clin Cancer Res; 2018 Dec; 37(1):324. PubMed ID: 30591064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
    Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
    J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIRLET7BHG promotes hepatocellular carcinoma progression by activating hepatic stellate cells through exosomal SMO to trigger Hedgehog pathway.
    Xia Y; Zhen L; Li H; Wang S; Chen S; Wang C; Yang X
    Cell Death Dis; 2021 Mar; 12(4):326. PubMed ID: 33771969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment.
    Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C
    Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic stellate cells activated by acidic tumor microenvironment promote the metastasis of hepatocellular carcinoma via osteopontin.
    Song J; Ge Z; Yang X; Luo Q; Wang C; You H; Ge T; Deng Y; Lin H; Cui Y; Chu W; Yao M; Zhang Z; Gu J; Fan J; Qin W
    Cancer Lett; 2015 Jan; 356(2 Pt B):713-20. PubMed ID: 25449435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
    Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
    Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.
    Mikuriya Y; Tashiro H; Kuroda S; Nambu J; Kobayashi T; Amano H; Tanaka Y; Ohdan H
    Int J Cancer; 2015 Feb; 136(4):E3-13. PubMed ID: 25053237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis.
    Huang JL; Fu YP; Gan W; Liu G; Zhou PY; Zhou C; Sun BY; Guan RY; Zhou J; Fan J; Yi Y; Qiu SJ
    Cancer Lett; 2020 Apr; 476():140-151. PubMed ID: 32061951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosome-depleted MiR-148a-3p derived from Hepatic Stellate Cells Promotes Tumor Progression via ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma.
    Zhang X; Chen F; Huang P; Wang X; Zhou K; Zhou C; Yu L; Peng Y; Fan J; Zhou J; Lu Z; Hu J; Wang Z
    Int J Biol Sci; 2022; 18(6):2249-2260. PubMed ID: 35414782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 17A promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expression.
    Li J; Lau GK; Chen L; Dong SS; Lan HY; Huang XR; Li Y; Luk JM; Yuan YF; Guan XY
    PLoS One; 2011; 6(7):e21816. PubMed ID: 21760911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Stellate Cells in Hepatocellular Carcinoma Promote Tumor Growth Via Growth Differentiation Factor 15 Production.
    Myojin Y; Hikita H; Sugiyama M; Sasaki Y; Fukumoto K; Sakane S; Makino Y; Takemura N; Yamada R; Shigekawa M; Kodama T; Sakamori R; Kobayashi S; Tatsumi T; Suemizu H; Eguchi H; Kokudo N; Mizokami M; Takehara T
    Gastroenterology; 2021 Apr; 160(5):1741-1754.e16. PubMed ID: 33346004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinase-activated receptor 2 (PAR2) in hepatic stellate cells - evidence for a role in hepatocellular carcinoma growth in vivo.
    Mußbach F; Ungefroren H; Günther B; Katenkamp K; Henklein P; Westermann M; Settmacher U; Lenk L; Sebens S; Müller JP; Böhmer FD; Kaufmann R
    Mol Cancer; 2016 Jul; 15(1):54. PubMed ID: 27473374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-bromo-7-methoxychrysin suppress stemness of SMMC-7721 cells induced by co-culture of liver cancer stem-like cells with hepatic stellate cells.
    Wen Q; Xu C; Zhou J; Liu NM; Cui YH; Quan MF; Cao JG; Ren KQ
    BMC Cancer; 2019 Mar; 19(1):224. PubMed ID: 30866863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-17A inhibits cell autophagy under starvation and promotes cell migration via TAB2/TAB3-p38 mitogen-activated protein kinase pathways in hepatocellular carcinoma.
    Zhou Y; Wu PW; Yuan XW; Li J; Shi XL
    Eur Rev Med Pharmacol Sci; 2016; 20(2):250-63. PubMed ID: 26875893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.